Peter Wilden
Chief Financial Officer
Finance
Ferring Pharmaceuticals
Israel
Biography
Dr. Peter Wilden joined Ferring in 1991 coming from the IT & Management Consulting sector. He has occupied several leading posts within the company and became Chief Financial Officer in 2000. Dr. Wilden has a profound background in corporate taxation. He holds a degree in Business Administration and Information Technology from the University of Kiel, as well as a Ph.D. in Business Administration. Since 2004 Dr. Wilden is member of the Board of Directors and Chairman of the Audit & Compliance Committee of Lonza Group AG,Basel.
Research Interest
Finance
